ChemAbout
© 2026 ChemAbout
Insights|Privacy Policy|Terms of Service|[email protected]
Home/Compounds/API/Gemfibrozil
C15H22O3
250.33 g/mol
APIWarning

Gemfibrozil

CAS25812-30-0EC247-280-2
Category
API
Compound Class
Organic Acid
Primary Use
Pharmaceutical Raw Material

Gemfibrozil is a compound used as an active pharmaceutical ingredient, primarily indicated for managing abnormal blood lipid levels. It is typically recommended alongside dietary changes and exercise, though it is generally less preferred than statins.

pharmaceutical raw material for lipid-modifying medicationsactive pharmaceutical ingredient in formulations for dyslipidemia

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing or supplying this compound?

List your inventory or post a purchase request

CAS 25812-30-0

List This Product
Sign in to publish supply information
Request This Product
Submit a request without registering

Related Compounds

ReferenceSame Category

FAP-2286?

CAS2581741-18-4

pharmaceutical raw material

ReferenceSame Category

Fospropofol

CAS258516-89-1

active pharmaceutical ingredient

ReferenceSame Category

Prajmalium bitartrate

CAS2589-47-1

pharmaceutical raw material

ReferenceSame Category

IDRX-42

CAS2590556-80-0

pharmaceutical raw material

Safety Reference

Corrosive
Corrosive
Toxic
Toxic
Harmful
Harmful
Health Hazard
Health Hazard
Environmental Hazard
Environmental Hazard
Warning
H302Harmful if swallowed
H351Suspected of causing cancer
H361Suspected of damaging fertility or the unborn child
H411Toxic to aquatic life with long lasting effects
H301Toxic if swallowed
H317May cause an allergic skin reaction
H318Causes serious eye damage
H410Very toxic to aquatic life with long lasting effects
Identifiers
IUPAC Name

5-(2,5-dimethylphenoxy)-2,2-dimethylpentanoic acid

InChIKey

HEMJJKBWTPKOJG-UHFFFAOYSA-N

SMILES

CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O

Synonyms (94)
  • 4TX
  • TEVA-A
  • Gemfibrozil (JAN/USP/INN)
  • Gemfibrozil for system suitability, European Pharmacopoeia (EP)
  • Gemfibrozil, British Pharmacopoeia (BP)
  • Gemfibrozil, European Pharmacopoeia (EP)
  • Gemfibrozil, United States Pharmacopeia (USP)
  • Gemfibrozilo [INN-Spanish]
  • Gemfibrozilum [INN-Latin]
  • ApoGemfibrozil
  • Ausgem
  • Bayvit, Gemfibrozilo
  • Bolutol
  • Brozil
  • Cholespid
  • Clearol
  • Decrelip
  • Elmogan
  • Emfib
  • Fetinor
  • Fibratol
  • Fibrocit
  • GEMFIBROZIL [MART.]
  • Gem-S
  • Gemcor
  • Gemd
  • Gemfibril
  • Gemfibromax
  • Gemfibrosil
  • Gemfibrozil (Lopid)
  • Gemfibrozil (Standard)
  • Gemfibrozil CRS
  • Gemfibrozil, GenRX
  • Gemfibrozil, Healthsense
  • Gemfibrozil, SBPA
  • Gemfibrozilo
  • Gemfibrozilum
  • Gemlipid
  • Gemnpid
  • Gen-Fibro
  • GenGemfibrozil
  • Genlip
  • Gevilon Uno
  • Gozid
  • Hidil
  • Hipolixan;
  • Innogem
  • Innogen
  • Ipolipid
  • Jezil
  • Lanaterom
  • Lifibron
  • Lipazil
  • Lipigem
  • Lipira
  • Lipizyl
  • Lipozid
  • Lipur
  • Litarek
  • Lopid
  • Lopid (TN)
  • Lopid R
  • Low-Lip
  • Micolip
  • Normolip
  • Novo Gemfibrozil
  • NuGemfibrozil
  • Organolipid
  • PMS Gemfibrozil
  • Pilder
  • Progemzal
  • Reducel
  • Regulip
  • Renabrazin
  • Sinelip
  • Synbrozil
  • Taborcil
  • Tentroc
  • Trialmin
  • WL-Gemfibrozil
  • gemfibrozil